+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Autoimmune Disease Diagnostics Market Research Report: By Product, Test Type, Application, End User - Industry Analysis and Growth Forecast to 2030

  • ID: 5184608
  • Report
  • July 2020
  • Region: Global
  • 266 Pages
  • Prescient & Strategic Intelligence Private Limited

FEATURED COMPANIES

  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • ELITech Group
  • Grifols S.A.
  • ORGENTEC Diagnostika GmbH
  • Siemens AG
  • MORE
According to a report by the publisher, the global autoimmune disease diagnostics market is projected to generate a revenue of $10,012.9 million by 2030, and is predicted to progress at an 8.5% CAGR during the time period 2020–2030. The market is being driven by the increasing geriatric population, rising incidence of autoimmune diseases, growing initiatives taken by various government and private organizations for raising awareness regarding autoimmune diseases, discovery of biomarkers, and surging strategic developments among major players.

On the basis of application, the autoimmune disease diagnostic market is divided into multiple sclerosis, rheumatoid arthritis (RA), systemic lupus erythematous, scleroderma, Sjogren’s syndrome, sarcoidosis, myasthenia gravis, and others. Out of all these, the RA division is projected to register the highest CAGR in the near future, which can be attributed to the rising awareness programs that are being organized by public and private organizations, growing cases of RA, and discovery of new biomarkers for the diagnosis of this diseases.

Geographically, North America is predicted to advance at the fastest pace in the coming years in the autoimmune disease diagnostics market. This can be owing to the widespread burden of autoimmune diseases, enhanced healthcare infrastructure, presence of established players, growing geriatric population, and rising research activities.

The major players operating in the autoimmune disease diagnostics market are Abbott Laboratories, Thermo Fisher Scientific Inc., bioMérieux S.A., Danaher Corporation, Siemens AG, Seramun Diagnostica GmbH, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Trinity Biotech plc, Exagen Inc., Cambridge Life Sciences Limited, , HYCOR Biomedical, Grifols S.A., ELITech Group, PerkinElmer Inc., Inova Diagnostics, Adaltis S.r.l., ORGENTEC Diagnostika GmbH, Bio-Rad Laboratories Inc., Sigma Diagnostics Inc., and A. Menarini Diagnostics S.r.l.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • ELITech Group
  • Grifols S.A.
  • ORGENTEC Diagnostika GmbH
  • Siemens AG
  • MORE

Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Product
1.3.2 Market Segmentation by Test Type
1.3.3 Market Segmentation by Application
1.3.4 Market Segmentation by End User
1.3.5 Market Segmentation by Region
1.3.6 Analysis Period
1.3.7 Market Data Reporting Unit
1.3.7.1 Value
1.4 Key Stakeholders

Chapter 2. Research Methodology
2.1 Secondary Research
2.1.1 Paid
2.1.2 Unpaid
2.2 Primary Research
2.2.1 Breakdown of Primary Research Respondents
2.2.1.1 By region
2.2.1.2 By industry participant
2.2.1.3 By company type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Currency Conversion Rates
2.6 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Product
4.1.1.1 Consumables and assay kits
4.1.1.1.1 ELISA
4.1.1.1.2 ANA IFA
4.1.1.1.3 RF and anti-CCP antibody
4.1.1.1.4 Others
4.1.1.2 Instruments
4.1.1.2.1 Automated
4.1.1.2.2 Semi-automated
4.1.2 By Test Type
4.1.2.1 Routine laboratory
4.1.2.2 Inflammatory marker
4.1.2.3 Autoantibodies and immunology
4.1.2.4 HLA
4.1.2.5 Cytokine
4.1.2.6 Flow cytometry
4.1.2.7 Others
4.1.3 By Application
4.1.3.1 RA
4.1.3.2 Multiple sclerosis
4.1.3.3 SLE
4.1.3.4 Sjögren's syndrome
4.1.3.5 Scleroderma
4.1.3.6 Myasthenia gravis
4.1.3.7 Sarcoidosis
4.1.3.8 Others
4.1.4 By End User
4.1.4.1 Hospitals
4.1.4.2 Diagnostic centers
4.1.4.3 Academic institutes and research centers
4.1.4.4 Others
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Discovering new biomarkers
4.2.1.2 Increasing strategic developments
4.2.2 Drivers
4.2.2.1 Widespread burden of autoimmune diseases
4.2.2.2 Increasing awareness about autoimmune diseases
4.2.2.3 Rising healthcare expenditure
4.2.2.4 Impact analysis of drivers on market forecast
4.2.3 Restraints
4.2.3.1 High purchase and maintenance cost of instruments
4.2.3.2 Impact analysis of restraints on market forecast
4.2.4 Opportunities
4.2.4.1 Awareness and extensive studies to identify autoimmune diseases
4.3 Porter’s Five Forces Analysis
4.3.1 Bargaining Power of Buyers
4.3.2 Bargaining Power of Suppliers
4.3.3 Intensity of Rivalry
4.3.4 Threat of New Entrants
4.3.5 Threat of Substitutes
4.4 Impact of COVID-19

Chapter 5. Global Market Size and Forecast
5.1 By Product
5.1.1 Consumables and Assay Kits, by Type
5.1.2 Instruments, by Type
5.2 By Test Type
5.3 By Application
5.4 By End User
5.5 By Region

Chapter 6. North America Market Size and Forecast
6.1 By Product
6.1.1 Consumables and Assay Kits, by Type
6.1.2 Instruments, by Type
6.2 Test Type
6.3 By Application
6.4 By End User
6.5 By Country
6.5.1 U.S. Autoimmune Disease Diagnostics Market
6.5.1.1 By product
6.5.1.1.1 Consumables and assay kits, by type
6.5.1.1.2 Instruments, by type
6.5.1.2 By test type
6.5.1.3 By application
6.5.1.4 By end user
6.5.2 Canada Autoimmune Disease Diagnostics Market
6.5.2.1 By product
6.5.2.1.1 Consumables and assay kits, by type
6.5.2.1.2 Instruments, by type
6.5.2.2 By test type
6.5.2.3 By application
6.5.2.4 By end user

Chapter 7. Europe Market Size and Forecast
7.1 By Product
7.1.1 Consumables and Assay Kits, by Type
7.1.2 Instruments, by Type
7.2 By Test Type
7.3 By Application
7.4 By End User
7.5 By Country
7.5.1 Germany Autoimmune Disease Diagnostics Market
7.5.1.1 By product
7.5.1.1.1 Consumables and assay kits, by type
7.5.1.1.2 Instruments, by type
7.5.1.2 By test type
7.5.1.3 By application
7.5.1.4 By end user
7.5.2 France Autoimmune Disease Diagnostics Market
7.5.2.1 By product
7.5.2.1.1 Consumables and assay kits, by type
7.5.2.1.2 Instruments, by type
7.5.2.2 By test type
7.5.2.3 By application
7.5.2.4 By end user
7.5.3 U.K. Autoimmune Disease Diagnostics Market
7.5.3.1 By product
7.5.3.1.1 Consumables and assay kits, by type
7.5.3.1.2 Instruments, by type
7.5.3.2 By test type
7.5.3.3 By application
7.5.3.4 By end user
7.5.4 Italy Autoimmune Disease Diagnostics Market
7.5.4.1 By product
7.5.4.1.1 Consumables and assay kits, by type
7.5.4.1.2 Instruments, by type
7.5.4.2 By test type
7.5.4.3 By application
7.5.4.4 By end user
7.5.5 Spain Autoimmune Disease Diagnostics Market
7.5.5.1 By product
7.5.5.1.1 Consumables and assay kits, by type
7.5.5.1.2 Instruments, by type
7.5.5.2 By test type
7.5.5.3 By application
7.5.5.4 By end user

Chapter 8. APAC Market Size and Forecast
8.1 By Product
8.1.1 Consumables and Assay Kits, by Type
8.1.2 Instruments, by Type
8.2 By Test Type
8.3 By Application
8.4 By End User
8.5 By Country
8.5.1 China Autoimmune Disease Diagnostics Market
8.5.1.1 By product
8.5.1.1.1 Consumables and assay kits, by type
8.5.1.1.2 Instruments, by type
8.5.1.2 By test type
8.5.1.3 By application
8.5.1.4 By end user
8.5.2 India Autoimmune Disease Diagnostics Market
8.5.2.1 By product
8.5.2.1.1 Consumables and assay kits, by type
8.5.2.1.2 Instruments, by type
8.5.2.2 By test type
8.5.2.3 By application
8.5.2.4 By end user
8.5.3 Japan Autoimmune Disease Diagnostics Market
8.5.3.1 By product
8.5.3.1.1 Consumables and assay kits, by type
8.5.3.1.2 Instruments, by type
8.5.3.2 By test type
8.5.3.3 By application
8.5.3.4 By end user

Chapter 9. LATAM Market Size and Forecast
9.1 By Product
9.1.1 Consumables and Assay Kits, by Type
9.1.2 Instruments, by Type
9.2 By Test Type
9.3 By Application
9.4 By End User
9.5 By Country

Chapter 10. MEA Market Size and Forecast
10.1 By Product
10.1.1 Consumables and Assay Kits, by Type
10.1.2 Instruments, by Type
10.2 By Test Type
10.3 By Application
10.4 By End User
10.5 By Country

Chapter 11. Competitive Landscape
11.1 Market Share Analysis of Key Players
11.2 Product Benchmarking of Key Players
11.3 Strategic Developments in the Market

Chapter 12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Business Overview
12.1.2 Product and Service Offerings
12.1.3 Key Financial Summary
12.2 Bio-Rad Laboratories Inc.
12.2.1 Business Overview
12.2.2 Product and Service Offerings
12.2.3 Key Financial Summary
12.3 Thermo Fisher Scientific Inc.
12.3.1 Business Overview
12.3.2 Product and Service Offerings
12.3.3 Key Financial Summary
12.4 Siemens AG
12.4.1 Business Overview
12.4.2 Product and Service Offerings
12.4.3 Key Financial Summary
12.5 Grifols S.A.
12.5.1 Business Overview
12.5.2 Product and Service Offerings
12.5.3 Key Financial Summary
12.6 Danaher Corporation
12.6.1 Business Overview
12.6.2 Product and Service Offerings
12.6.3 Key Financial Summary
12.7 F. Hoffmann-La Roche Ltd.
12.7.1 Business Overview
12.7.2 Product and Service Offerings
12.7.3 Key Financial Summary
12.8 PerkinElmer Inc.
12.8.1 Business Overview
12.8.2 Product and Service Offerings
12.8.3 Key Financial Summary
12.9 DiaSorin S.p.A.
12.9.1 Business Overview
12.9.2 Product and Service Offerings
12.9.3 Key Financial Summary
12.10 Trinity Biotech plc
12.10.1 Business Overview
12.10.2 Product and Service Offerings
12.10.3 Key Financial Summary
12.11 bioMérieux S.A.
12.11.1 Business Overview
12.11.2 Product and Service Offerings
12.11.3 Key Financial Summary
12.12 A. Menarini Diagnostics S.r.l.
12.12.1 Business Overview
12.12.2 Product and Service Offerings
12.13 Cambridge Life Sciences Limited
12.13.1 Business Overview
12.13.2 Product and Service Offerings
12.14 Seramun Diagnostica GmbH
12.14.1 Business Overview
12.14.2 Product and Service Offerings
12.15 Exagen Inc.
12.15.1 Business Overview
12.15.2 Product and Service Offerings
12.15.3 Key Financial Summary
12.16 HYCOR Biomedical
12.16.1 Business Overview
12.16.2 Product and Service Offerings
12.17 ELITech Group
12.17.1 Business Overview
12.17.2 Product and Service Offerings
12.18 Inova Diagnostics
12.18.1 Business Overview
12.18.2 Product and Service Offerings
12.19 Adaltis S.r.l.
12.19.1 Business Overview
12.19.2 Product and Service Offerings
12.20 ORGENTEC Diagnostika GmbH
12.20.1 Business Overview
12.20.2 Product and Service Offerings
12.21 Sigma Diagnostics Inc.
12.21.1 Business Overview
12.21.2 Product and Service Offerings

Chapter 13. Appendix
13.1 Abbreviations
13.2 Sources and References
13.3 Related Reports

LIST OF TABLES
TABLE 1 ANALYSIS PERIOD OF THE STUDY
TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
TABLE 4 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014–2019)
TABLE 5 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020–2030)
TABLE 6 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014–2019)
TABLE 7 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020–2030)
TABLE 8 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014–2019)
TABLE 9 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020–2030)
TABLE 10 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014–2019)
TABLE 11 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020–2030)
TABLE 12 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014–2019)
TABLE 13 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020–2030)
TABLE 14 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014–2019)
TABLE 15 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020–2030)
TABLE 16 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY REGION, $M (2014–2019)
TABLE 17 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY REGION, $M (2020–2030)
TABLE 18 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014–2019)
TABLE 19 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020–2030)
TABLE 20 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014–2019)
TABLE 21 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020–2030)
TABLE 22 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014–2019)
TABLE 23 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020–2030)
TABLE 24 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014–2019)
TABLE 25 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020–2030)
TABLE 26 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014–2019)
TABLE 27 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020–2030)
TABLE 28 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014–2019)
TABLE 29 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020–2030)
TABLE 30 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2014–2019)
TABLE 31 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2020–2030)
TABLE 32 U.S. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014–2019)
TABLE 33 U.S. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020–2030)
TABLE 34 U.S. AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014–2019)
TABLE 35 U.S. AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020–2030)
TABLE 36 U.S. AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014–2019)
TABLE 37 U.S. AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020–2030)
TABLE 38 U.S. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014–2019)
TABLE 39 U.S. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020–2030)
TABLE 40 U.S. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014–2019)
TABLE 41 U.S. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020–2030)
TABLE 42 U.S. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014–2019)
TABLE 43 U.S. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020–2030)
TABLE 44 CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014–2019)
TABLE 45 CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020–2030)
TABLE 46 CANADA AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014–2019)
TABLE 47 CANADA AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020–2030)
TABLE 48 CANADA AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014–2019)
TABLE 49 CANADA AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020–2030)
TABLE 50 CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014–2019)
TABLE 51 CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020–2030)
TABLE 52 CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014–2019)
TABLE 53 CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020–2030)
TABLE 54 CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014–2019)
TABLE 55 CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020–2030)
TABLE 56 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014–2019)
TABLE 57 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020–2030)
TABLE 58 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014–2019)
TABLE 59 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020–2030)
TABLE 60 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014–2019)
TABLE 61 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020–2030)
TABLE 62 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014–2019)
TABLE 63 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020–2030)
TABLE 64 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014–2019)
TABLE 65 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020–2030)
TABLE 66 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014–2019)
TABLE 67 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020–2030)
TABLE 68 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2014–2019)
TABLE 69 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2020–2030)
TABLE 70 GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014–2019)
TABLE 71 GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020–2030)
TABLE 72 GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014–2019)
TABLE 73 GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020–2030)
TABLE 74 GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014–2019)
TABLE 75 GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020–2030)
TABLE 76 GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014–2019)
TABLE 77 GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020–2030)
TABLE 78 GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014–2019)
TABLE 79 GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020–2030)
TABLE 80 GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014–2019)
TABLE 81 GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020–2030)
TABLE 82 FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014–2019)
TABLE 83 FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020–2030)
TABLE 84 FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014–2019)
TABLE 85 FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020–2030)
TABLE 86 FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014–2019)
TABLE 87 FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020–2030)
TABLE 88 FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014–2019)
TABLE 89 FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020–2030)
TABLE 90 FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014–2019)
TABLE 91 FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020–2030)
TABLE 92 FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014–2019)
TABLE 93 FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020–2030)
TABLE 94 U.K. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014–2019)
TABLE 95 U.K. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020–2030)
TABLE 96 U.K. AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014–2019)
TABLE 97 U.K. AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020–2030)
TABLE 98 U.K. AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014–2019)
TABLE 99 U.K. AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020–2030)
TABLE 100 U.K. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014–2019)
TABLE 101 U.K. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020–2030)
TABLE 102 U.K. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014–2019)
TABLE 103 U.K. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020–2030)
TABLE 104 U.K. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014–2019)
TABLE 105 U.K. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020–2030)
TABLE 106 ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014–2019)
TABLE 107 ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020–2030)
TABLE 108 ITALY AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014–2019)
TABLE 109 ITALY AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020–2030)
TABLE 110 ITALY AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014–2019)
TABLE 111 ITALY AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020–2030)
TABLE 112 ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014–2019)
TABLE 113 ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020–2030)
TABLE 114 ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014–2019)
TABLE 115 ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020–2030)
TABLE 116 ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014–2019)
TABLE 117 ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020–2030)
TABLE 118 SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014–2019)
TABLE 119 SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020–2030)
TABLE 120 SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014–2019)
TABLE 121 SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020–2030)
TABLE 122 SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014–2019)
TABLE 123 SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020–2030)
TABLE 124 SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014–2019)
TABLE 125 SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020–2030)
TABLE 126 SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014–2019)
TABLE 127 SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020–2030)
TABLE 128 SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014–2019)
TABLE 129 SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020–2030)
TABLE 130 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014–2019)
TABLE 131 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020–2030)
TABLE 132 APAC AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014–2019)
TABLE 133 APAC AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020–2030)
TABLE 134 APAC AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014–2019)
TABLE 135 APAC AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020–2030)
TABLE 136 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014–2019)
TABLE 137 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020–2030)
TABLE 138 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014–2019)
TABLE 139 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020–2030)
TABLE 140 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014–2019)
TABLE 141 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020–2030)
TABLE 142 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2014–2019)
TABLE 143 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2020–2030)
TABLE 144 CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014–2019)
TABLE 145 CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020–2030)
TABLE 146 CHINA AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014–2019)
TABLE 147 CHINA AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020–2030)
TABLE 148 CHINA AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014–2019)
TABLE 149 CHINA AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020–2030)
TABLE 150 CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014–2019)
TABLE 151 CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020–2030)
TABLE 152 CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014–2019)
TABLE 153 CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020–2030)
TABLE 154 CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014–2019)
TABLE 155 CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020–2030)
TABLE 156 INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014–2019)
TABLE 157 INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020–2030)
TABLE 158 INDIA AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014–2019)
TABLE 159 INDIA AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020–2030)
TABLE 160 INDIA AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014–2019)
TABLE 161 INDIA AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020–2030)
TABLE 162 INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014–2019)
TABLE 163 INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020–2030)
TABLE 164 INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014–2019)
TABLE 165 INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020–2030)
TABLE 166 INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014–2019)
TABLE 167 INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020–2030)
TABLE 168 JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014–2019)
TABLE 169 JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020–2030)
TABLE 170 JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014–2019)
TABLE 171 JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020–2030)
TABLE 172 JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014–2019)
TABLE 173 JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020–2030)
TABLE 174 JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014–2019)
TABLE 175 JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020–2030)
TABLE 176 JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014–2019)
TABLE 177 JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020–2030)
TABLE 178 JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014–2019)
TABLE 179 JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020–2030)
TABLE 180 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014–2019)
TABLE 181 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020–2030)
TABLE 182 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014–2019)
TABLE 183 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020–2030)
TABLE 184 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014–2019)
TABLE 185 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020–2030)
TABLE 186 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014–2019)
TABLE 187 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020–2030)
TABLE 188 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014–2019)
TABLE 189 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020–2030)
TABLE 190 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014–2019)
TABLE 191 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020–2030)
TABLE 192 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2014–2019)
TABLE 193 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2020–2030)
TABLE 194 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014–2019)
TABLE 195 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020–2030)
TABLE 196 MEA AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014–2019)
TABLE 197 MEA AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020–2030)
TABLE 198 MEA AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014–2019)
TABLE 199 MEA AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020–2030)
TABLE 200 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014–2019)
TABLE 201 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020–2030)
TABLE 202 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014–2019)
TABLE 203 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020–2030)
TABLE 204 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014–2019)
TABLE 205 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020–2030)
TABLE 206 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2014–2019)
TABLE 207 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2020–2030)
TABLE 208 PRODUCT BENCHMARKING OF KEY PLAYERS
TABLE 209 ABBOTT LABORATORIES – AT A GLANCE
TABLE 210 ABBOTT LABORATORIES – KEY FINANCIAL SUMMARY
TABLE 211 BIO-RAD LABORATORIES INC. – AT A GLANCE
TABLE 212 BIO-RAD LABORATORIES INC. – KEY FINANCIAL SUMMARY
TABLE 213 THERMO FISHER SCIENTIFIC INC. – AT A GLANCE
TABLE 214 THERMO FISHER SCIENTIFIC INC. – KEY FINANCIAL SUMMARY
TABLE 215 SIEMENS AG – AT A GLANCE
TABLE 216 SIEMENS AG – KEY FINANCIAL SUMMARY
TABLE 217 GRIFOLS S.A. – AT A GLANCE
TABLE 218 GRIFOLS S.A. – KEY FINANCIAL SUMMARY
TABLE 219 DANAHER CORPORATION – AT A GLANCE
TABLE 220 DANAHER CORPORATION – KEY FINANCIAL SUMMARY
TABLE 221 F. HOFFMANN-LA ROCHE LTD. – AT A GLANCE
TABLE 222 F. HOFFMANN-LA ROCHE LTD. – KEY FINANCIAL SUMMARY
TABLE 223 PERKINELMER INC. – AT A GLANCE
TABLE 224 PERKINELMER INC. – KEY FINANCIAL SUMMARY
TABLE 225 DIASORIN S.P.A. – AT A GLANCE
TABLE 226 DIASORIN S.P.A. – PRODUCT AND SERVICE OFFERINGS
TABLE 227 DIASORIN S.P.A. – KEY FINANCIAL SUMMARY
TABLE 228 TRINITY BIOTECH PLC – AT A GLANCE
TABLE 229 TRINITY BIOTECH PLC. – KEY FINANCIAL SUMMARY
TABLE 230 BIOMÉRIEUX S.A. – AT A GLANCE
TABLE 231 BIOMÉRIEUX S.A. – KEY FINANCIAL SUMMARY
TABLE 232 A. MENARINI DIAGNOSTICS S.R.L. – AT A GLANCE
TABLE 233 CAMBRIDGE LIFE SCIENCES LIMITED – AT A GLANCE
TABLE 234 SERAMUN DIAGNOSTICA GMBH – AT A GLANCE
TABLE 235 EXAGEN INC. – AT A GLANCE
TABLE 236 EXAGEN INC. – KEY FINANCIAL SUMMARY
TABLE 237 HYCOR BIOMEDICAL – AT A GLANCE
TABLE 238 ELITECH GROUP – AT A GLANCE
TABLE 239 INOVA DIAGNOSTICS – AT A GLANCE
TABLE 240 ADALTIS S.R.L. – AT A GLANCE
TABLE 241 ORGENTEC DIAGNOSTIKA GMBH – AT A GLANCE
TABLE 242 SIGMA DIAGNOSTICS INC. – AT A GLANCE

LIST OF FIGURES
FIG 1 RESEARCH SCOPE
FIG 2 RESEARCH METHODOLOGY
FIG 3 BREAKDOWN OF PRIMARY RESEARCH BY REGION
FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
FIG 6 DATA TRIANGULATION APPROACH
FIG 7 CURRENCY CONVERSION RATES FOR USD (2019)
FIG 8 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SUMMARY
FIG 9 BARGAINING POWER OF BUYERS
FIG 10 BARGAINING POWER OF SUPPLIERS
FIG 11 INTENSITY OF RIVALRY
FIG 12 THREAT OF NEW ENTRANTS
FIG 13 THREAT OF SUBSTITUTES
FIG 14 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SNAPSHOT
FIG 15 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014–2030)
FIG 16 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014–2030)
FIG 17 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014–2030)
FIG 18 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014–2030)
FIG 19 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014–2030)
FIG 20 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014–2030)
FIG 21 WORLDWIDE MAJOR MARKETS FOR AUTOIMMUNE DISEASE DIAGNOSTICS PRODUCTS
FIG 22 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY REGION, $M (2014–2030)
FIG 23 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SNAPSHOT
FIG 24 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014–2030)
FIG 25 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014–2030)
FIG 26 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014–2030)
FIG 27 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014–2030)
FIG 28 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014–2030)
FIG 29 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014–2030)
FIG 30 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2014–2030)
FIG 31 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SNAPSHOT
FIG 32 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014–2030)
FIG 33 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014–2030)
FIG 34 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014–2030)
FIG 35 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014–2030)
FIG 36 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014–2030)
FIG 37 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014–2030)
FIG 38 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2014–2030)
FIG 39 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SNAPSHOT
FIG 40 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014–2030)
FIG 41 APAC AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014–2030)
FIG 42 APAC AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014–2030)
FIG 43 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014–2030)
FIG 44 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014–2030)
FIG 45 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014–2030)
FIG 46 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2014–2030)
FIG 47 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SNAPSHOT
FIG 48 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014–2030)
FIG 49 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014–2030)
FIG 50 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014–2030)
FIG 51 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014–2030)
FIG 52 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014–2030)
FIG 53 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014–2030)
FIG 54 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2014–2030)
FIG 55 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SNAPSHOT
FIG 56 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014–2030)
FIG 57 MEA AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014–2030)
FIG 58 MEA AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014–2030)
FIG 59 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014–2030)
FIG 60 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014–2030)
FIG 61 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014–230)
FIG 62 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2014–2030)
FIG 63 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SHARE ANALYSIS OF KEY PLAYERS (2019)
FIG 64 ABBOTT LABORATORIES – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 65 BIO-RAD LABORATORIES INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 66 THERMO FISHER SCIENTIFIC INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 67 SIEMENS AG – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 68 GRIFOLS S.A. – REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2019)
FIG 69 DANAHER CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 70 F. HOFFMANN-LA ROCHE LTD. – REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2019)
FIG 71 PERKINELMER INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 72 DIASORIN S.P.A. – REVENUE SPLIT BY TECHNOLOGY AND GEOGRAPHY (2019)
FIG 73 TRINITY BIOTECH PLC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 74 BIOMÉRIEUX S.A. – REVENUE SPLIT BY APPLICATION AND GEOGRAPHY (2018)

Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • Siemens AG
  • Grifols S.A.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer Inc.
  • DiaSorin S.p.A.
  • Trinity Biotech plc
  • bioMérieux S.A.
  • A. Menarini Diagnostics S.r.l.
  • Cambridge Life Sciences Limited
  • Seramun Diagnostica GmbH
  • Exagen Inc.
  • HYCOR Biomedical
  • ELITech Group
  • Inova Diagnostics
  • Adaltis S.r.l.
  • ORGENTEC Diagnostika GmbH
  • Sigma Diagnostics Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll